{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:01:44Z","timestamp":1780066904604,"version":"3.54.0"},"reference-count":36,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/qlhg1014","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T23:43:22Z","timestamp":1722383002000},"page":"3639-3651","source":"Crossref","is-referenced-by-count":6,"title":["Protective effect of N-acetylcysteine against hepatocellular carcinoma in hepatitis B virus carriers"],"prefix":"10.62347","volume":"14","author":[{"given":"Szu-Yuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A and Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 2019; 16: 589-604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: a global view","volume":"7","author":"Yang","year":"2010","unstructured":"Yang JD and Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010; 7: 448-458.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Fattovich G, Stroffolini T, Zagni I and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127 Suppl 1: S35-S50.","DOI":"10.1053\/j.gastro.2004.09.014"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000074999","article-title":"Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan","volume":"46","author":"Kao","year":"2003","unstructured":"Kao JH. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology 2003; 46: 400-407.","journal-title":"Intervirology"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Chen DS. Hepatocellular carcinoma in Taiwan. Hepatol Res 2007; 37 Suppl 2: S101-S105.","DOI":"10.1111\/j.1872-034X.2007.00170.x"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Levrero M and Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016; 64: S84-S101.","DOI":"10.1016\/j.jhep.2016.02.021"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/cdd.2015.129","article-title":"HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3","volume":"23","author":"Yuan","year":"2016","unstructured":"Yuan K, Lei Y, Chen HN, Chen Y, Zhang T, Li K, Xie N, Wang K, Feng X, Pu Q, Yang W, Wu M, Xiang R, Nice EC, Wei Y and Huang C. HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3. Cell Death Differ 2016; 23: 616-627.","journal-title":"Cell Death Differ"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/JHC.S307962","article-title":"The mechanisms of HBV-induced hepatocellular carcinoma","volume":"8","author":"Jiang","year":"2021","unstructured":"Jiang Y, Han Q, Zhao H and Zhang J. The mechanisms of HBV-induced hepatocellular carcinoma. J Hepatocell Carcinoma 2021; 8: 435-450.","journal-title":"J Hepatocell Carcinoma"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s000180300001","article-title":"Molecular mechanisms of N-acetylcysteine actions","volume":"60","author":"Zafarullah","year":"2003","unstructured":"Zafarullah M, Li WQ, Sylvester J and Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003; 60: 6-20.","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1097\/MEG.0b013e32833aa11b","article-title":"Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity","volume":"22","author":"Baniasadi","year":"2010","unstructured":"Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR and Velayati AA. Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol 2010; 22: 1235-1238.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref10","unstructured":"Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician 2009; 80: 265-269."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1378\/chest.107.5.1437","article-title":"N-acetylcysteine for lung cancer prevention","volume":"107","author":"van Zandwijk","year":"1995","unstructured":"van Zandwijk N. N-acetylcysteine for lung cancer prevention. Chest 1995; 107: 1437-1441.","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/antiox10020169","article-title":"Possible beneficial effects of n-acetylcysteine for treatment of triple-negative breast cancer","volume":"10","author":"Kwon","year":"2021","unstructured":"Kwon Y. Possible beneficial effects of n-acetylcysteine for treatment of triple-negative breast cancer. Antioxidants (Basel) 2021; 10: 169.","journal-title":"Antioxidants (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Lin H, Liu XB, Yu JJ, Hua F and Hu ZW. Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS\/ER stress in TLR2 deficient mouse. PLoS One 2013; 8: e74130.","DOI":"10.1371\/journal.pone.0074130"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"30269","DOI":"10.3390\/ijms161226225","article-title":"Oxidative stress and inflammation in hepatic diseases: therapeutic possibilities of N-acetylcysteine","volume":"16","author":"Andrade KQ","year":"2015","unstructured":"De Andrade KQ, Moura FA, Dos Santos JM, De Araújo OR, de Farias Santos JC and Goulart MO. Oxidative stress and inflammation in hepatic diseases: therapeutic possibilities of N-acetylcysteine. Int J Mol Sci 2015; 16: 30269-30308.","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1007\/s10620-019-05652-0","article-title":"N-acetylcysteine prevents post-embolization syndrome in patients with hepatocellular carcinoma following transarterial chemoembolization","volume":"64","author":"Siramolpiwat","year":"2019","unstructured":"Siramolpiwat S, Punjachaipornpon T, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Tangaroonsanti A, Bhanthumkomol P, Phumyen A, Yasiri A and Kaewmanee M. N-acetylcysteine prevents post-embolization syndrome in patients with hepatocellular carcinoma following transarterial chemoembolization. Dig Dis Sci 2019; 64: 3337-3345.","journal-title":"Dig Dis Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/jcsm.13162","article-title":"Comparison of surgical complications after curative surgery in patients with oral cavity squamous cell carcinoma and sarcopenia","volume":"14","author":"Zeng","year":"2023","unstructured":"Zeng S, Chang CH, Sun M, Chen WM, Wu SY and Zhang J. Comparison of surgical complications after curative surgery in patients with oral cavity squamous cell carcinoma and sarcopenia. J Cachexia Sarcopenia Muscle 2023; 14: 576-584.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/liv.15656","article-title":"Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM","volume":"43","author":"SY","year":"2023","unstructured":"Wu SY, Chen WM, Chiang MF, Lo HC, Wu MS, Lee MC and Soong RS. Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM. Liver Int 2023; 43: 2232-2244.","journal-title":"Liver Int"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"101393","DOI":"10.1016\/j.diabet.2022.101393","article-title":"Effects of H1-antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitus","volume":"49","author":"SY","year":"2023","unstructured":"Wu SY, Chen WM, Chen YC, Chiang MF, Lee MC and Soong RS. Effects of H1-antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitus. Diabetes Metab 2023; 49: 101393.","journal-title":"Diabetes Metab"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/brain\/awad366","article-title":"Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction","volume":"147","author":"Sun","year":"2024","unstructured":"Sun M, Chen WM, Wu SY and Zhang J. Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction. Brain 2024; 147: 1474-1482.","journal-title":"Brain"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jtho.2023.04.005","article-title":"Statin use during concurrent chemoradiotherapy with improved survival outcomes in esophageal squamous cell carcinoma: a propensity score-matched nationwide cohort study","volume":"18","author":"Chen","year":"2023","unstructured":"Chen WM, Yu YH, Chen M, Shia BC and Wu SY. Statin use during concurrent chemoradiotherapy with improved survival outcomes in esophageal squamous cell carcinoma: a propensity score-matched nationwide cohort study. J Thorac Oncol 2023; 18: 1082-1093.","journal-title":"J Thorac Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2147\/copd.2006.1.4.425","article-title":"Role of N-acetylcysteine in the management of COPD","volume":"1","author":"Sadowska","year":"2006","unstructured":"Sadowska AM, Verbraecken J, Darquennes K and De Backer WA. Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis 2006; 1: 425-434.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011; 10: 150-161.","journal-title":"Pharm Stat"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/apt.14835","article-title":"Association between proton pump inhibitors and the risk of hepatocellular carcinoma","volume":"48","author":"Shao","year":"2018","unstructured":"Shao YJ, Chan TS, Tsai K and Wu SY. Association between proton pump inhibitors and the risk of hepatocellular carcinoma. Aliment Pharmacol Ther 2018; 48: 460-468.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2010.11.014","article-title":"Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges","volume":"305","author":"Bouchard","year":"2011","unstructured":"Bouchard MJ and Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett 2011; 305: 123-143.","journal-title":"Cancer Lett"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","unstructured":"Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, Raimondo G and Levrero M. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A 2009; 106: 19975-19979.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","article-title":"Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice","volume":"59","author":"Chisari","year":"1989","unstructured":"Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL and Palmiter RD. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145-1156.","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.3748\/wjg.v16.i39.4932","article-title":"HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN\/Akt pathway","volume":"16","author":"HL","year":"2010","unstructured":"Ha HL and Yu DY. HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN\/Akt pathway. World J Gastroenterol 2010; 16: 4932-7.","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"De Vries N and De Flora S. N-acetyl-l-cysteine. J Cell Biochem Suppl 1993; 17F: 270-277.","DOI":"10.1002\/jcb.240531040"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4161\/cbt.9.2.10583","article-title":"N-acetylcysteine, reactive oxygen species and beyond","volume":"9","author":"Sun","year":"2010","unstructured":"Sun SY. N-acetylcysteine, reactive oxygen species and beyond. Cancer Biol Ther 2010; 9: 109-10.","journal-title":"Cancer Biol Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/carcin\/22.7.999","article-title":"Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points","volume":"22","author":"Flora S","year":"2001","unstructured":"De Flora S, Izzotti A, D’Agostini F and Balansky RM. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001; 22: 999-1013.","journal-title":"Carcinogenesis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jnci\/92.12.977","article-title":"For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups","volume":"92","author":"Van Zandwijk","year":"2000","unstructured":"Van Zandwijk N, Dalesio O, Pastorino U, de Vries N and van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst 2000; 92: 977-986.","journal-title":"J Natl Cancer Inst"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1177\/1078155219900788","article-title":"Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: a randomized, double blind, placebo-controlled, clinical trial","volume":"26","author":"Bondad","year":"2020","unstructured":"Bondad N, Boostani R, Barri A, Elyasi S and Allahyari A. Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: a randomized, double blind, placebo-controlled, clinical trial. J Oncol Pharm Pract 2020; 26: 1575-1582.","journal-title":"J Oncol Pharm Pract"},{"key":"ref33","unstructured":"Pillai K, Mekkawy AH, Akhter J, Badar S, Dong L, Liu AI and Morris DL. Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine - an in vitro study with pancreatic and hepatic cancer cells. Am J Transl Res 2020; 12: 7404-7419."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/alcalc\/agad044","article-title":"N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebocontrolled trial","volume":"58","author":"Morley","year":"2023","unstructured":"Morley KC, Peruch S, Adams C, Towers E, Tremonti C, Watt J, Jamshidi N and Haber PS. N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebocontrolled trial. Alcohol Alcohol 2023; 58: 553-560.","journal-title":"Alcohol Alcohol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/antiox9121283","article-title":"N-acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation in NAFLD: a comprehensive analysis of the literature","volume":"9","author":"Dludla","year":"2020","unstructured":"Dludla PV, Nkambule BB, Mazibuko-Mbeje SE, Nyambuya TM, Marcheggiani F, Cirilli I, Ziqubu K, Shabalala SC, Johnson R, Louw J, Damiani E and Tiano L. N-acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation in NAFLD: a comprehensive analysis of the literature. Antioxidants (Basel) 2020; 9: 1283.","journal-title":"Antioxidants (Basel)"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/7\/ajcr0157705.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:54:34Z","timestamp":1766022874000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/7\/ajcr0157705.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/qlhg1014","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}